{"editorial":{"content_id":"552a0d51-db47-4db6-a659-2161ab4a4b58","slug":"anvisa-20261117-71f3b9","content_type":"news","title":"Anvisa暂停销售不合规膳食补充剂并召回相关产品","summary":"巴西国家卫生监督局11月17日暂停多款不合规膳食补充剂的销售、分销、生产、进口、广告和使用，并要求召回产品。","body":"巴西国家卫生监督局（Anvisa）于11月17日（周二）暂停了全国范围内不合规膳食补充剂的商业化销售，措施包括召回产品，并暂停这些补充剂的销售、分销、生产、进口、广告宣传和使用。此次措施涉及3家企业、4款产品。\n\n被点名的产品之一是Norvy Saúde Ltda.（CNPJ: 66.132.561/0001-52）的液体褪黑素喷雾补充剂Melatonina Spray-Norvy。Anvisa指出，该成分的舌下使用安全性未经评估，且产品广告中出现未经该局批准的宣称，如“入睡时起效更快”和“更快入睡”。\n\n决议还暂停了Nutrymed Indústria Farmacêutica e Alimentícia Ltda.（CNPJ: 40.624.113/0001-82）生产的全部补充剂。戈亚尼亚（Goiânia）卫生监督局对该企业进行卫生检查后，发现生产存在严重缺陷。检查报告列出的问题包括原料储存不当、保质期过期、缺乏质量控制、储存区域有污物、结构缺陷、交叉流动、水质不适于饮用等。\n\n此外，Morbach Nutri Complementos Alimentares Ltda.（CNPJ: 53.635.572/0001-03）生产的两款产品也被暂停：Nutri Bluwey胶囊膳食补充剂和Nutri AN-T胶囊膳食补充剂。Anvisa称，这些产品通知中提交的文件已被取消，且不足以证明其符合适用卫生法规的要求，尤其是在成分、质量、安全性和稳定性方面；缺乏或不足的技术要素妨碍了卫生合规性核查，构成对消费者健康的风险。\n\nAnvisa还指出，上述产品中发现了未经授权作为技术辅料用于膳食补充剂的成分，以及未达到规定的最低钙含量限制。相关决议为第4.500/2026号，已在《联邦官方公报》（DOU）上公布。","why_it_matters":null,"cbi_observation":null,"direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["合规","政策","公共事件","br-health"],"content_level":"编辑整理","event_type":"政策法规","audience_tags":[],"event_location":null,"verification_status":"source_verified","published_at":"2026-11-17T17:01:28.103Z","display_date":"2026-11-17","source_published_at":null,"source_url":"https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/venda-de-suplementos-alimentares-irregulares-e-suspensa-pela-anvisa","source_name":"Anvisa","source_language":"pt","author_name":"编辑部","risk_level":"low","risk_flags":[],"opportunity_flags":[],"trend_signals":[]},"intelligence":null,"meta":{"canonical_url":"https://chinabrazilinsight.com/news/anvisa-20261117-71f3b9","api_url":"https://chinabrazilinsight.com/api/public/content/anvisa-20261117-71f3b9","markdown_url":"https://chinabrazilinsight.com/api/public/content/anvisa-20261117-71f3b9?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/anvisa-20261117-71f3b9?view=json","last_updated":"2026-11-17T17:01:53.665Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}